• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

07/04/2026 13:35

Accretion Pharma. - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Accretion Pharmaceuticals Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter ended on 31st March, 2026.